Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

Clinical trial NCT05361707 · UNKNOWN

Trial details

NCT number: NCT05361707
Sponsor: Vanda Pharmaceuticals
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Autism Spectrum Disorder Sleep Disorder Neurological Disorder Sleep Disturbance

Start date: 2021-07-28
Primary completion: 2025-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.